ERBB2 and breast carcinoma: Here, we provide detailed evidence supporting the function of ESR1-CCDC170 in endowing breast cancer cell survival and reducing endocrine sensitivity in vitro and in vivo and unravel its novel action mechanism via modulating and activating the SRC/HER2/HER3 complex.